New asthma pill targets root inflammation in early trial

NCT ID NCT06435273

Summary

This study tested whether a new oral medicine called AZD4604 could reduce inflammation in the airways of adults with moderate-to-severe asthma. For 4 weeks, 36 participants took either the drug or a placebo pill, and researchers measured changes in cells and genes from lung samples. The goal was to see if blocking a specific inflammation pathway could help control the underlying disease process in asthma.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Calgary, Alberta, T2N 4Z6, Canada

  • Research Site

    Vancouver, British Columbia, V5Z 1M9, Canada

  • Research Site

    Montreal, Quebec, H4A 3J1, Canada

  • Research Site

    Québec, Quebec, G1V 4G5, Canada

  • Research Site

    København NV, 2400, Denmark

  • Research Site

    Frankfurt, 60596, Germany

  • Research Site

    Großhansdorf, 22927, Germany

  • Research Site

    Barcelona, 8025, Spain

  • Research Site

    Palma de Mallorca, 07010, Spain

  • Research Site

    Santander, 39008, Spain

  • Research Site

    Birmingham, B9 5SS, United Kingdom

  • Research Site

    Glasgow, G12 0YN, United Kingdom

  • Research Site

    Headington, OX3 9DU, United Kingdom

  • Research Site

    Leicester, LE3 9QP, United Kingdom

  • Research Site

    Liverpool, L7 8YE, United Kingdom

  • Research Site

    London, W12 0HS, United Kingdom

  • Research Site

    Manchester, M23 9QZ, United Kingdom

  • Research Site

    Southampton, SO9 4XY, United Kingdom

Conditions

Explore the condition pages connected to this study.